Computer-assisted multifactorial method development for the streamlined separation and analysis of multicomponent mixtures in (Bio)pharmaceutical settings.

This study focuses on computer-assisted multifactorial method development for the streamlined separation and analysis of multicomponent mixtures in (bio)pharmaceutical settings.. The research employs high-performance liquid chromatography (HPLC) techniques to address analytical challenges in the pharmaceutical field. The (bio)pharmaceutical industry is rapidly moving towards complex drug modalities that require a commensurate level of analytical enabling technologies that can be deployed at a fast pace. Unsystematic method development and unnecessary manual intervention remain a major barrier towards a more efficient deployment of meaningful analytical assay across emerging modalities.... Research Background and Significance The pharmaceutical and biopharmaceutical industries are experiencing a paradigm shift characterized by the emergence of increasingly complex drug modalities such as biologics, antibody-drug conjugates, and novel small molecule combinations. These advancements necessitate robust analytical methods capable of efficiently separating and quantifying multiple components within intricate mixtures. Traditional HPLC method development, often reliant on trial-and-error and manual adjustments, is time-consuming and may lack reproducibility. This study by Hemida et al. addresses these challenges by leveraging computer-assisted multifactorial method development to streamline HPLC-based separation and analysis processes. The integration of computational tools allows for systematic evaluation of multiple chromatographic parameters simultaneously, enhancing method robustness and reducing development timelines. This approach aligns with the industry's demand for faster analytical assay deployment without compromising data quality, thus holding significant potential